MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Early cortical signature of development of visual hallucinations in ‘de novo’ Parkinson’s disease

    H. Bejr-kasem, J. Pagonabarraga, S. Martínez-Horta, F. Sampedro, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore, in patients with newly diagnosed Parkinson's disease (PD), grey matter volume (GMV) differences at baseline in those participants who will develop hallucinations…
  • 2018 International Congress

    Prevalence of non-motor symptoms in Parkinson’s disease and its impact on quality of life in a tertiary care center in India

    M. Karri, B. Ramasamy, R. Kalidoss (Coimbatore, India)

    Objective: To study the prevalence of Non-Motor Symptoms (NMS) in Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL). Background: PD is…
  • 2018 International Congress

    Sleep Disturbances and Quality of Life in People with Parkinson’s disease

    U. Chotphoksap, D. Tan, S.B. Tan, EK. Tan, S. Wang, J. Chew, E. Poh, X. Chen, T.Y. Kam, K. Prakash (Singapore, Singapore)

    Objective: To explore sleep disturbances in Parkinson’s disease (PD) patients and to investigate their associations with fatigue, mood, cognition and function, and their contribution to…
  • 2018 International Congress

    Altered amplitude of low-frequency fluctuations and functional connectivity in excessive daytime sleepiness in Parkinson disease

    X. Wang, K. Zhang (Nanjing, China)

    Objective: The present study aimed to explore the neural mechanism of Excessive daytime sleepiness (EDS) in Parkinson disease (PD). Background: EDS is common in PD,…
  • 2018 International Congress

    Subjective and objective urinary dysfunction in parkinson’s disease and atypical parkinsonisms

    Y. Lee, J. Kim (Seoul, Republic of Korea)

    Objective: To assess the relationship between subjective and objective urinary dysfunction in patients with Parkinson's disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy…
  • 2018 International Congress

    Natural history of RBD in Parkinson´s disease and response to dopaminergic and non-dopaminergic antiparkinsonian treatment

    M. Ruiz-Lopez, V. Bruno, ME. Freitas, R. Rajalingam, A. Chang, S. Fox, A. Lang (Toronto, ON, Canada)

    Objective: To assess the natural history of rapid eye movement sleep behavior disorder (RBD) in patients with Parkinson´s disease (PD) and clarify its response to…
  • 2018 International Congress

    Impact of Late-onset REM Sleep Behavior Disorder on the Symptoms of Parkinson’s Disease

    Y. Saitoh, M. Murata, Y. Takahashi (Tokyo, Japan)

    Objective: To investigate whether PSG-proven late-onset RBD is associated with the PD symptoms in the Japanese population. Background: Rapid eye movement sleep behavior disorder (RBD)…
  • 2018 International Congress

    Non-motor symptoms of Parkinson’s disease: Evaluation of urinary disorders

    K. Karbozova. (Bishkek, Kyrgyzstan)

    Objective: Violation of urination, as a manifestation of autonomic failure is common to many patients with Parkinson's disease (PD) and is a very actual. Background:…
  • 2018 International Congress

    Non motor symptoms in parkinsonism: A cross sectional study

    V. Kataria, V. Goyal (New Delhi, India)

    Objective: Non motor symptoms (NMS) in idiopathic Parkinson’s disease (PD) are well studied and has an effect on quality of life in PD. NMS in…
  • 2018 International Congress

    Dyspnea in Parkinson’s disease: A biomarker of disease’s severity?

    G. Baille, T. Perez, F. Machuron, L. Defebvre, C. Chenivesse, C. Moreau (Lille, France)

    Objective: The aim of our study was to determine the prevalence of dyspnea in a monocentric cohort of 153 non-demented PD patients (mean age: 63.9…
  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley